Medindia LOGIN REGISTER
Medindia

Estrogen Makes Precancerous Cells Deadly in the Oral Cavity

by Tanya Thomas on Jan 5 2011 9:30 AM

Researchers at Fox Chase Cancer Center have found that estrogen may increase the movement of precancerous cells in the mouth and thus promote the spread of the disease

 Estrogen Makes Precancerous Cells Deadly in the Oral Cavity
Researchers at Fox Chase Cancer Center have found that estrogen may increase the movement of precancerous cells in the mouth and thus promote the spread of the disease within the oral cavity.
Margie Clapper, co-leader of the Cancer Prevention and Control Program at Fox Chase Cancer Center and colleagues had previously reported that estrogen metabolism changes following smoke exposure in the lungs and may contribute to lung cancer.

To find out if this female hormone influences development of head and neck cancer, Ekaterina Shatalova, of the Fox Chase Cancer Center and researcher on this study, examined the impact of estrogen on precancerous and cancerous cells.

They found that estrogen induces the expression of an enzyme called cytochrome P450 1B1 (CYP1B1), which is responsible for breaking down toxins and metabolizing estrogen.

Interestingly, CYP1B1 induction occurred only in precancerous cells, which are neither totally normal nor cancerous. Surprisingly, estrogen did not induce CYP1B1 in cancer cells.

With closer investigation, the researchers found that depleting the expression of CYP1B1 diminished the ability of precancerous cells to move and divide, as compared to similar cells with normal levels of CYP1B1.

Estrogen also reduced cell death in the precancerous cells, irrespective of the amount of CYP1B1 present.

Advertisement
"In the future, we would like to find a natural or dietary agent to deplete the CYP1B1 enzyme and see if we can prevent oral cancer at the precancerous stage," said Shatalova.

"Our previous studies showed that the CYP1B1 enzyme sits at the hub of changes that occur in the lungs after smoke exposure. We were now able to look at its role in a more direct fashion by removing it from precancerous cells of the oral cavity.

Advertisement
"We found that cells lacking it move slower. CYP1B1 could be a wonderful target in precancerous lesions of the head and neck, because by attacking it, we might stop these lesions from progressing or moving to a more advanced stage," said Clapper.hese results may help researchers to "understand factors that cause head and neck cancer, in addition to the traditional risk factors of tobacco and alcohol exposure," said Jennifer R. Grandis, of the Head and Neck Cancer Program at the University of Pittsburgh School of Medicine.

The findings were published in the journal Cancer Prevention Research, a journal of the American Association for Cancer Research.

Source-ANI


Advertisement